PharVision Advisers’s PROG Holdings PRG Stock Holding History

PharVision Advisers’s Portfolio PRG Stock Details PRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,380	Closed	-$483K	–	517
2025 Q4	$483K	Buy	+16,380	New	+$488K	0.24%	48
2025 Q1	–	Sell	-6,813	Closed	-$288K	–	469
2024 Q4	$288K	Buy	+6,813	New	+$315K	0.24%	173

Other funds holding PRG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BICM

Breach Inlet Capital Management Mt. Pleasant, South Carolina $305M AUM 7.94% 1-Year Est. Return

PharVision Advisers's PRG Position: Q1 2026 in Review

PharVision Advisers sold out of PROG Holdings (PRG) in Q1 2026, closing a stake of 16,380 shares — an estimated $483K sold.

PharVision Advisers first reported a position in PRG in Q4 2024 and held it in 2 quarters. The position peaked at $483K in Q4 2025. 272 funds tracked by Wall St. Rank hold PRG as of Q1 2026.

PharVision Advisers reported no remaining PROG Holdings position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 16,380 PROG Holdings shares in Q1 2026, an estimated $483K.
PharVision Advisers first reported a position in PROG Holdings in Q4 2024 and held it in 2 quarters.
PharVision Advisers's PROG Holdings position peaked at $483K in Q4 2025.
272 funds tracked by Wall St. Rank held PROG Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.